126 related articles for article (PubMed ID: 9679582)
21. [Single instillation of epirubicin for the prophylaxis of recurrent primary superficial bladder carcinoma].
Liu B; Zhang Y; Wang Z; Ding Q; Chen B; Wang J; Jiang H
Zhonghua Wai Ke Za Zhi; 2002 Feb; 40(2):112-5. PubMed ID: 11955393
[TBL] [Abstract][Full Text] [Related]
22. Feasibility of early intravesical instillation chemotherapy after transurethral resection of the bladder: a prospective evaluation in a consecutive series of 210 cases.
Engeler DS; Wyler S; Neyer M; Hobi C; Müller J; Schmid HP
Scand J Urol Nephrol; 2008; 42(6):522-7. PubMed ID: 18609290
[TBL] [Abstract][Full Text] [Related]
23. [Continuous intravesical instillation of epirubicin immediately after transurethral resection of superficial bladder cancer: a prospective controlled study].
Maekawa S; Suzuki H; Ohkubo K; Aoki Y; Okada T; Maeda H; Ogura K; Arai Y
Hinyokika Kiyo; 2000 May; 46(5):301-6. PubMed ID: 10876750
[TBL] [Abstract][Full Text] [Related]
24. [Short-duration bladder instillation therapy with pirarubicin for superficial bladder tumor based on pharmacodynamic study].
Nakagawa S; Kojima M; Takada H; Sugimoto K; Mikami K; Watanabe H
Gan To Kagaku Ryoho; 1992 Sep; 19(11):1873-7. PubMed ID: 1519929
[TBL] [Abstract][Full Text] [Related]
25. Pilot study of intravesical instillation of two new generation anthracycline antibiotics in prevention of superficial bladder cancer recurrence.
Chen SY; DU LD; Zhang YH
Chin Med J (Engl); 2010 Dec; 123(23):3422-6. PubMed ID: 22166525
[TBL] [Abstract][Full Text] [Related]
26. [Intravesical instillation therapy of aclacinomycin-A (ACM) for superficial bladder tumor].
Noguchi S; Kubota Y; Shuin T; Miura T; Moriyama M; Sakuramoto T; Oshima H
Hinyokika Kiyo; 1984 Sep; 30(9):1153-8. PubMed ID: 6596878
[TBL] [Abstract][Full Text] [Related]
27. Intravesical chemotherapy with epirubicin: a dose response study.
Masters JR; Popert RJ; Thompson PM; Gibson D; Coptcoat MJ; Parmar MK
J Urol; 1999 May; 161(5):1490-3. PubMed ID: 10210379
[TBL] [Abstract][Full Text] [Related]
28. 2-micrometer continuous wave laser treatment for multiple non-muscle-invasive bladder cancer with intravesical instillation of epirubicin.
Liu H; Xue S; Ruan Y; Sun X; Han B; Xia S
Lasers Surg Med; 2011 Jan; 43(1):15-20. PubMed ID: 21254138
[TBL] [Abstract][Full Text] [Related]
29. A randomized study of short-versus long-term intravesical epirubicin instillation for superficial bladder cancer. Nagoya University Urological Oncology Group.
Okamura K; Kinukawa T; Tsumura Y; Otani T; Itoh H; Kobayashi H; Matsuura O; Kobayashi M; Fukatsu T; Ohshima S
Eur Urol; 1998; 33(3):285-8; discussion 289. PubMed ID: 9555553
[TBL] [Abstract][Full Text] [Related]
30. A randomized controlled trial of short-term versus long-term prophylactic intravesical instillation chemotherapy for recurrence after transurethral resection of Ta/T1 transitional cell carcinoma of the bladder.
Koga H; Kuroiwa K; Yamaguchi A; Osada Y; Tsuneyoshi M; Naito S
J Urol; 2004 Jan; 171(1):153-7. PubMed ID: 14665865
[TBL] [Abstract][Full Text] [Related]
31. Sequential bacillus Calmette-Guerin and epirubicin versus bacillus Calmette-Guerin alone for superficial bladder tumors: a randomized prospective study.
Ali-El-Dein B; Nabeeh A; Ismail EH; Ghoneim MA
J Urol; 1999 Aug; 162(2):339-42. PubMed ID: 10411034
[TBL] [Abstract][Full Text] [Related]
32. [Cooperative phase II study of epirubicin (EPI) in bladder cancer, renal pelvic and ureteral tumors--Urological Cooperative Study Group of EPI].
Niijima T; Koyanagi T; Maru A; Sakashita S; Koiso K; Ishikawa H; Uchida K; Shimazaki J; Isaka S; Akaza H
Hinyokika Kiyo; 1986 Sep; 32(9):1359-69. PubMed ID: 3468792
[TBL] [Abstract][Full Text] [Related]
33. Bacillus Calmette-Guerin versus epirubicin for primary, secondary or concurrent carcinoma in situ of the bladder: results of a European Organization for the Research and Treatment of Cancer--Genito-Urinary Group Phase III Trial (30906).
de Reijke TM; Kurth KH; Sylvester RJ; Hall RR; Brausi M; van de Beek K; Landsoght KE; Carpentier P;
J Urol; 2005 Feb; 173(2):405-9. PubMed ID: 15643181
[TBL] [Abstract][Full Text] [Related]
34. [Intravesical instillation of doxorubicin or epirubicin for chemoprophylaxis of superficial bladder cancer--the fifth study of the Japanese Urological Cancer Research Group for Adriamycin/Farumorubicin].
Hinotsu S; Akaza H; Isaka S; Kagawa S; Koiso K; Kotake T; Machida T; Matsumura Y; Niijima T; Obata K; Ohashi Y; Ohe H; Shimazaki J; Tashiro K;
Gan To Kagaku Ryoho; 2002 Jan; 29(1):73-80. PubMed ID: 11816482
[TBL] [Abstract][Full Text] [Related]
35. Delayed high-dose intravesical epirubicin therapy of superficial bladder cancer. A way to reduce the side effects and increase the efficacy--a phase 2 trial.
Bassi P; Spinadin R; Longo F; Saraeb S; Pappagallo GL; Zattoni F; Pagano F
Urol Int; 2002; 68(4):216-9. PubMed ID: 12053020
[TBL] [Abstract][Full Text] [Related]
36. [Short-term intravesical instillation of pirarubicin (THP) in prophylactic treatment after transurethral resection of superficial bladder tumor].
Kuroda K; Ishii N; Fukasawa K; Shirai M; Tajima M; Matsushima M; Miura K; Takanami M; Matsuhashi M; Kuwabara T; Matsumoto H; Sugita M
Hinyokika Kiyo; 1998 Aug; 44(8):547-52. PubMed ID: 9783189
[TBL] [Abstract][Full Text] [Related]
37. [Intravesical chemotherapy with 4'-EPI-adriamycin in patients with superficial bladder tumors (randomized study)].
Tsushima T; Matsumura Y; Ozaki Y; Akagi T; Obama T; Nasu Y; Ohmori H
Hinyokika Kiyo; 1985 Dec; 31(12):2215-8. PubMed ID: 3868934
[TBL] [Abstract][Full Text] [Related]
38. [Prophylaxis of recurrence in superficial bladder carcinoma by intravesical chemotherapy--comparative study between instillation of combined double anticancer agents and single anticancer agent].
Ikeda R; Chikazawa I; Kobayashi Y; Shiroma K; Nakade T; Suga K; Shiba N; Nakajima C; Moriyama M; Kawamura K; Miyazawa K; Tanaka T; Tsugawa R; Suzuki K; Sato H; Kikuyama A
Gan To Kagaku Ryoho; 1999 Mar; 26(4):509-14. PubMed ID: 10097748
[TBL] [Abstract][Full Text] [Related]
39. One immediate postoperative instillation of chemotherapy in low risk Ta, T1 bladder cancer patients. Is it always safe?
Oddens JR; van der Meijden AP; Sylvester R
Eur Urol; 2004 Sep; 46(3):336-8. PubMed ID: 15306104
[TBL] [Abstract][Full Text] [Related]
40. P53 mutation predicts intravesical adriamycin instillation failure in superficial transitional cell carcinoma of bladder.
Shiraishi K; Eguchi S; Mohri J; Kamiryo Y
Anticancer Res; 2003; 23(4):3475-8. PubMed ID: 12926093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
